Anavex Life Sciences Corp (AVXL)

[Investor2014]

I think that it is the usual context missing sound bites from Anavex that raises more questions and that really annoys me. It is annoying because Anavex should understand that it will annoyed anyone with a good understanding biotech statistics and only fools the fools who can't get past a headline and soundbites.

Then again so far it is only a conference abstract.